Stocks been consolidating in 1.8s, looks ready for a bounce. shorts from higher range so anytime this stock runs up fast, should cause a squeeze.
Craig Hallum has a Price Target $10.00
Lots of catalysts coming coming quarters: We intend to release two or three new single and panel tests per quarter for the remainder of this year, focusing on the two most prevalent cancers--colorectal and lung, as well as melanoma, which is especially amenable to targeted therapies.”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.